US 10526297
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted A61KA61K31/155A61K31/165
Quick answer
US patent 10526297 (Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases) held by United Kingdom Research and Innovation expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Kingdom Research and Innovation
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/155, A61K31/165, A61K31/216, A61K31/44